- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06345729
Une étude de MK-1084 plus pembrolizumab (MK-3475) chez des participants atteints du mutant KRAS G12C, d'un cancer du poumon non à petites cellules (CPNPC) métastatique avec un score de proportion de tumeur (TPS) programmé de ligand de mort cellulaire 1 (PD-L1) ≥ 50 % (MK-1084-004)
Une étude de phase 3, randomisée, en double aveugle et multicentrique sur le MK-1084 en association avec le pembrolizumab par rapport au pembrolizumab plus placebo comme traitement de première intention des participants atteints d'un CPNPC métastatique mutant KRAS G12C avec PD-L1 TPS ≥ 50 %
This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with identified Kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation and programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. There is one primary study hypothesis:
Combination of calderasib and pembrolizumab is superior to placebo plus pembrolizumab with respect to progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Per Protocol Amendment 04, overall survival (OS) was moved to be a secondary outcome measure. Additionally, no new participants will be offered Second Course treatment for pembrolizumab.
Type d'étude
Inscription (Estimé)
Phase
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: Toll Free Number
- Numéro de téléphone: 1-888-577-8839
- E-mail: Trialsites@msd.com
Lieux d'étude
-
-
Baden-Wurttemberg
-
Stuttgart, Baden-Wurttemberg, Allemagne, 70199
- Recrutement
- Marienhospital Stuttgart ( Site 1302)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +49711064893273
-
-
Mecklenburg-Vorpommern
-
Greifswald, Mecklenburg-Vorpommern, Allemagne, 17489
- Recrutement
- Universitätsmedizin Greifswald ( Site 1308)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +4938348622006
-
-
North Rhine-Westphalia
-
Bielefeld, North Rhine-Westphalia, Allemagne, 33611
- Recrutement
- Evangelisches Krankenhaus Bielefeld - Johannesstift ( Site 1307)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0521 772 75504
-
Solingen, North Rhine-Westphalia, Allemagne, 42699
- Recrutement
- Krankenhaus Bethanien ( Site 1303)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +49212636661
-
-
-
-
Buenos Aires
-
Berazategui, Buenos Aires, Argentine, B1884BBF
- Recrutement
- Centro de Oncología e Investigación de Buenos Aires ( Site 0308)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +541142262013
-
CABA, Buenos Aires, Argentine, C1019ABS
- Complété
- AUSTRAL MEDICAL CENTER ( Site 0302)
-
CABA, Buenos Aires, Argentine, C1426AGE
- Recrutement
- Centro Oncologico Korben ( Site 0304)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 1157507952
-
Mar del Plata, Buenos Aires, Argentine, B7600FZO
- Recrutement
- Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 02234963224
-
-
Río Negro Province
-
Viedma, Río Negro Province, Argentine, R8500ACE
- Recrutement
- Clinica Viedma S. A ( Site 0307)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +54 2920 42-8700
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentine, S2000DEJ
- Recrutement
- Fundacion Estudios Clinicos ( Site 0306)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +543412221472
-
Rosario, Santa Fe Province, Argentine, S2000DSV
- Recrutement
- Sanatorio Parque ( Site 0301)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +54341420-0222
-
-
-
-
New South Wales
-
Camperdown, New South Wales, Australie, 2050
- Recrutement
- Chris O'Brien Lifehouse ( Site 3000)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +61285140140
-
-
Queensland
-
Urraween, Queensland, Australie, 4655
- Recrutement
- Cancer Care Service Hervey Bay ( Site 3003)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +610743256110
-
-
Victoria
-
Frankston, Victoria, Australie, 3199
- Recrutement
- Frankston Hospital ( Site 3002)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +61397847777
-
-
Western Australia
-
Nedlands, Western Australia, Australie, 6009
- Recrutement
- One Clinical Research ( Site 3001)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +61862799466
-
-
-
-
-
Rio de Janeiro, Brésil, 22775-001
- Recrutement
- Americas ( Site 0431)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +552133852088
-
Rio de Janeiro, Brésil, 20230-130
- Recrutement
- Instituto Nacional de Câncer - INCA ( Site 0446)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +552132076564
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brésil, 30380-472
- Recrutement
- Hospital Mario Penna ( Site 0436)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +553132999543
-
-
Pernambuco
-
Recife, Pernambuco, Brésil, 50040-000
- Recrutement
- Hospital de Câncer de Recife ( Site 0447)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +558132178084
-
-
Piauí
-
Teresina, Piauí, Brésil, 64049-200
- Complété
- Oncoclínica Oncologistas Associados ( Site 0441)
-
-
Rio Grande do Norte
-
Natal, Rio Grande do Norte, Brésil, 59062-000
- Recrutement
- Liga Norte Riograndense Contra o Câncer ( Site 0439)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +558440095595
-
-
Rio Grande do Sul
-
Ijuí, Rio Grande do Sul, Brésil, 98700 000
- Recrutement
- Hospital de Caridade de Ijuí ( Site 0438)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +5555991221138
-
Passo Fundo, Rio Grande do Sul, Brésil, 99010-260
- Recrutement
- Hospital de Clínicas de Passo Fundo ( Site 0442)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +5554981271411
-
Porto Alegre, Rio Grande do Sul, Brésil, 90050-170
- Recrutement
- Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro Multidisciplinar de Pesquisa Clínica ( Site 0435)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +555132148143
-
-
São Paulo
-
Barretos, São Paulo, Brésil, 14784-400
- Recrutement
- Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0437)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +551733216638
-
-
-
-
-
Pleven, Bulgarie, 5804
- Recrutement
- MHAT - Heart and Brain ( Site 1006)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +35988030371
-
Plovdiv, Bulgarie, 4000
- Recrutement
- Medical Center Futuremeds ( Site 1007)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +359886744494
-
Plovdiv, Bulgarie, 4004
- Recrutement
- Complex Oncology Center - Plovdiv EOOD ( Site 1003)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +359 32 277 240
-
-
Pazardzhik
-
Panagyurishte, Pazardzhik, Bulgarie, 4500
- Recrutement
- MBAL Uni Hospital-Department of Medical Oncology ( Site 1000)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +35935788581
-
-
Sofia (stolitsa)
-
Sofia, Sofia (stolitsa), Bulgarie, 1632
- Recrutement
- Multiprofile Hospital for Active Treatment SerdikaМЕD EOOD-Second Department of Medical Oncology ( Site 1002)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +35929049100
-
-
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 0V9
- Recrutement
- CancerCare Manitoba ( Site 0210)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 204-787-4156
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Recrutement
- QEII Health Sciences Centre - Victoria General Site-Dept. of Medical Oncology ( Site 0208)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 9024737964
-
-
Ontario
-
Hamilton, Ontario, Canada, L8V 5C2
- Recrutement
- Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 9053879495
-
Toronto, Ontario, Canada, M4N 3M5
- Recrutement
- Sunnybrook Research Institute ( Site 0206)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 4164805000x687435
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1M5
- Recrutement
- St. Marys Hospital Center ( Site 0204)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 5143453511
-
Trois-Rivières, Quebec, Canada, G8Z 3R9
- Recrutement
- Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0207)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 8196973333x63238
-
-
-
-
Maule Region
-
Talca, Maule Region, Chili, 3465584
- Recrutement
- Clinica Universidad Catolica del Maule-Oncology ( Site 0500)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +56947532700
-
-
Region M. de Santiago
-
Santiago, Region M. de Santiago, Chili, 7500713
- Recrutement
- Orlandi Oncologia-Oncology ( Site 0503)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +56226057491
-
Santiago, Region M. de Santiago, Chili, 7500921
- Recrutement
- FALP-UIDO ( Site 0501)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +56224205098
-
Santiago, Region M. de Santiago, Chili, 8420383
- Recrutement
- Bradfordhill-Clinical Area ( Site 0504)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +56229490970
-
Santiago, Region M. de Santiago, Chili, 7560913
- Recrutement
- Centro de Oncología de Precisión ( Site 0502)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 56991612199
-
-
-
-
Anhui
-
Hefei, Anhui, Chine, 230031
- Actif, ne recrute pas
- Anhui Provincial Cancer Hospital ( Site 3136)
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Chine, 100142
- Actif, ne recrute pas
- Beijing Cancer hospital ( Site 3133)
-
Beijing, Beijing Municipality, Chine, 100142
- Actif, ne recrute pas
- Beijing Cancer hospital ( Site 3134)
-
Beijing, Beijing Municipality, Chine, 100730
- Actif, ne recrute pas
- Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102)
-
Beijing, Beijing Municipality, Chine, 101149
- Actif, ne recrute pas
- Beijing Chest Hospital,Capital Medical University ( Site 3104)
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, Chine, 400030
- Actif, ne recrute pas
- Chongqing University Cancer Hospital ( Site 3119)
-
Chongqing, Chongqing Municipality, Chine, 400042
- Complété
- Army Medical Center of People's Liberation Army ( Site 3142)
-
-
Fujian
-
Fuzhou, Fujian, Chine, 350014
- Actif, ne recrute pas
- Fujian Cancer Hospital ( Site 3127)
-
Xiamen, Fujian, Chine, 361003
- Actif, ne recrute pas
- The First Affiliated hospital of Xiamen University ( Site 3148)
-
-
Guangdong
-
Guangzhou, Guangdong, Chine, 510160
- Complété
- The First Affiliated Hospital of Guangzhou Medical University ( Site 3108)
-
Guangzhou, Guangdong, Chine, 510515
- Actif, ne recrute pas
- Southern Medical University Nanfang Hospital ( Site 3128)
-
Guangzhou, Guangdong, Chine, 510555
- Complété
- Sun Yat-sen University Cancer Center ( Site 3137)
-
-
Heilongjiang
-
Harbin, Heilongjiang, Chine, 150081
- Actif, ne recrute pas
- Harbin Medical University Cancer Hospital ( Site 3123)
-
Jiamusi, Heilongjiang, Chine, 154007
- Actif, ne recrute pas
- JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124)
-
-
Henan
-
Zhengzhou, Henan, Chine, 450008
- Actif, ne recrute pas
- Henan Cancer Hospital ( Site 3149)
-
-
Hubei
-
Wuhan, Hubei, Chine, 430000
- Actif, ne recrute pas
- Tongji Hospital Tongji Medical,Science & Technology ( Site 3113)
-
Wuhan, Hubei, Chine, 430079
- Actif, ne recrute pas
- Hubei Cancer Hospital ( Site 3126)
-
-
Hunan
-
Changsha, Hunan, Chine, 410011
- Complété
- The Second Xiangya Hospital of Central South University ( Site 3130)
-
Changsha, Hunan, Chine, 410013
- Actif, ne recrute pas
- Hunan Cancer Hospital ( Site 3141)
-
-
Jiangsu
-
Nanjing, Jiangsu, Chine, 210008
- Actif, ne recrute pas
- Nanjing Gulou Hospital ( Site 3122)
-
Nanjing, Jiangsu, Chine, 210012
- Complété
- Nanjing First Hospital ( Site 3154)
-
Suzhou, Jiangsu, Chine, 215006
- Complété
- The First Affiliated Hospital of Soochow University ( Site 3146)
-
Wuxi, Jiangsu, Chine, 214122
- Actif, ne recrute pas
- Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155)
-
-
Jiangxi
-
Nanchang, Jiangxi, Chine, 330000
- Complété
- The Second Affiliated Hospital of Nanchang University ( Site 3139)
-
Nanchang, Jiangxi, Chine, 330006
- Actif, ne recrute pas
- The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138)
-
-
Jilin
-
Changchun, Jilin, Chine, 130012
- Actif, ne recrute pas
- Jilin Province Tumor Hospital ( Site 3107)
-
-
Shaanxi
-
Xi'an, Shaanxi, Chine, 710000
- Complété
- The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150)
-
-
Shandong
-
Jinan, Shandong, Chine, 250117
- Actif, ne recrute pas
- Shandong Cancer Hospital ( Site 3116)
-
Linyi, Shandong, Chine, 276001
- Actif, ne recrute pas
- LinYi Cancer Hospital ( Site 3111)
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Chine, 200030
- Actif, ne recrute pas
- Shanghai Chest Hospital ( Site 3100)
-
Shanghai, Shanghai Municipality, Chine, 200032
- Actif, ne recrute pas
- Fudan University Shanghai Cancer Center ( Site 3144)
-
Shanghai, Shanghai Municipality, Chine, 200032
- Actif, ne recrute pas
- Zhongshan Hospital,Fudan University ( Site 3143)
-
-
Shanxi
-
Taiyuan, Shanxi, Chine, 030000
- Actif, ne recrute pas
- Shanxi Cancer Hospital ( Site 3131)
-
Xian, Shanxi, Chine, 710038
- Complété
- The Second Affiliated Hospital of Air Force Medical University ( Site 3117)
-
Xian, Shanxi, Chine, 710038
- Actif, ne recrute pas
- The Second Affiliated Hospital of Air Force Medical University ( Site 3152)
-
-
Sichuan
-
Chengdu, Sichuan, Chine, 610000
- Actif, ne recrute pas
- West China Hospital, Sichuan University ( Site 3140)
-
Chengdu, Sichuan, Chine, 610031
- Actif, ne recrute pas
- The Third People's Hospital of Chengdu (CDTPH) ( Site 3157)
-
Chengdu, Sichuan, Chine, 610042
- Actif, ne recrute pas
- Sichuan Cancer hospital. ( Site 3109)
-
Neijiang, Sichuan, Chine, 641000
- Actif, ne recrute pas
- The Second People's Hospital of Neijiang ( Site 3105)
-
-
Xinjiang
-
Ürümqi, Xinjiang, Chine, 830000
- Complété
- Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101)
-
-
Yunnan
-
Kunming, Yunnan, Chine, 650107
- Actif, ne recrute pas
- Yunnan Province Cancer Hospital ( Site 3153)
-
-
Zhejiang
-
Hangzhou, Zhejiang, Chine, 310006
- Actif, ne recrute pas
- The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
-
Hangzhou, Zhejiang, Chine, 310016
- Actif, ne recrute pas
- Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121)
-
Linhai, Zhejiang, Chine, 317000
- Actif, ne recrute pas
- Taizhou Hospital of Zhejiang Province ( Site 3145)
-
Wenzhou, Zhejiang, Chine, 325015
- Actif, ne recrute pas
- The First Affiliated Hospital of Wenzhou Medical University ( Site 3151)
-
-
-
-
Cesar Department
-
Valledupar, Cesar Department, Colombie, 200001
- Recrutement
- Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +573122354788
-
-
Cundinamarca
-
Bogota, Cundinamarca, Colombie, 110111
- Recrutement
- Clinica Oncologica Colsubsidio ( Site 4003)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +573142059194
-
-
Risaralda Department
-
Pereira, Risaralda Department, Colombie, 660001
- Recrutement
- Oncologos del Occidente ( Site 4005)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +57 3187715522
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, Colombie, 76001
- Recrutement
- Hemato Oncologos SA ( Site 4002)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +573167711932
-
-
-
-
-
Incheon, Corée du Sud, 22332
- Recrutement
- Inha University Hospital ( Site 3610)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82328901038
-
Seoul, Corée du Sud, 02447
- Recrutement
- Kyung Hee University Hospital ( Site 3605)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 82-2-958-8511
-
Seoul, Corée du Sud, 08308
- Recrutement
- Korea University Guro Hospital ( Site 3601)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82226261914
-
Seoul, Corée du Sud, 03312
- Recrutement
- The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82220304340
-
Seoul, Corée du Sud, 02841
- Recrutement
- Korea University Anam Hospital ( Site 3609)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +8229206409
-
-
Incheon
-
Bupyeong-gu, Incheon, Corée du Sud, 21431
- Recrutement
- The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82-32-280-6474
-
-
Jeonranamdo
-
Hwasun, Jeonranamdo, Corée du Sud, 58128
- Complété
- Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604)
-
-
Kyonggi-do
-
Suwon, Kyonggi-do, Corée du Sud, 16247
- Recrutement
- The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 82-31-244-7983
-
-
Kyongsangnam-do
-
Yangsan, Kyongsangnam-do, Corée du Sud, 50612
- Recrutement
- Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82-55-360-1415
-
-
Taegu-Kwangyokshi
-
Daegu, Taegu-Kwangyokshi, Corée du Sud, 42415
- Recrutement
- Yeungnam University Hospital ( Site 3607)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82536203848
-
Daegu, Taegu-Kwangyokshi, Corée du Sud, 42601
- Recrutement
- Keimyung University Dongsan Hospital ( Site 3611)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +82532587737
-
-
Taejon-Kwangyokshi
-
Junggu, Taejon-Kwangyokshi, Corée du Sud, 35015
- Recrutement
- Chungnam national university hospital ( Site 3602)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 82-42-257-5753
-
-
-
-
-
San José, Costa Rica, 10103
- Recrutement
- Onco Tech, S.A. ( Site 4102)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +50622586260
-
-
-
-
-
Barcelona, Espagne, 08035
- Recrutement
- Hospital Universitari Vall d Hebron ( Site 2010)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34 932 543 450
-
Madrid, Espagne, 28040
- Recrutement
- Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2017)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 34915504800x253900
-
Madrid, Espagne, 28006
- Recrutement
- Hospital Universitario La Princesa ( Site 2020)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34915202200
-
Málaga, Espagne, 29010
- Recrutement
- Hospital Universitario Virgen de la Victoria ( Site 2021)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0034671594566
-
Seville, Espagne, 41009
- Recrutement
- Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2015)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 34954712941
-
-
Barcelona
-
Vic, Barcelona, Espagne, 08500
- Recrutement
- H. General de Vic ( Site 2022)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34937027732
-
-
Las Palmas
-
Las Palmas de Gran Canaria, Las Palmas, Espagne, 35001
- Recrutement
- Hospital Insular de Gran Canaria-Oncology ( Site 2019)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34 928441738
-
-
Madrid, Comunidad de
-
Leganés, Madrid, Comunidad de, Espagne, 28911
- Recrutement
- Hospital Universitario Severo Ochoa ( Site 2024)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34914818000
-
Madrid, Madrid, Comunidad de, Espagne, 28009
- Recrutement
- HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2012)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34 915868115
-
-
Malaga
-
Málaga, Malaga, Espagne, 29011
- Recrutement
- H.R.U Málaga - Hospital General-Oncology ( Site 2014)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +34 951308130
-
-
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, France, 06000
- Recrutement
- Centre Hospitalier Universitaire de Nice - Hopital Pasteur ( Site 1108)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33492038281
-
-
Bourgogne-Franche-Comté
-
Dijon, Bourgogne-Franche-Comté, France, 21000
- Recrutement
- Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1103)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33380293772
-
-
Gard
-
Nîmes, Gard, France, 30029
- Recrutement
- Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 1106)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33 4 66 68 32 21
-
-
Nord
-
Valenciennes, Nord, France, 59304
- Recrutement
- Clinique Teissier Groupe ( Site 1100)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33327142337
-
-
Puy-de-Dome
-
Clermont-Ferrand, Puy-de-Dome, France, 63003
- Recrutement
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1101)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33473278005
-
-
Vaucluse
-
Avignon, Vaucluse, France, 84000
- Recrutement
- Centre Hospitalier d'Avignon-Service d'Oncologie médicale et d'hématologie clinique ( Site 1104)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33432753333
-
-
Île-de-France Region
-
Boulogne-Billancourt, Île-de-France Region, France, 92100
- Recrutement
- Hôpital Ambroise Paré-Department of Respiratory Diseases and Thoracic Oncology ( Site 1105)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +33149095806
-
-
-
-
-
Thessaloniki, Grèce, 570 10
- Recrutement
- G. Papanikolaou General Hospital-Pulmonary Clinic of Aristotle University of Thessaloniki ( Site 1405)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0030 231330787476
-
Thessaloniki, Grèce, 570 01
- Recrutement
- European Interbalkan Medical Center ( Site 1404)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302310380000
-
-
Achaia
-
Pátrai, Achaia, Grèce, 26504
- Recrutement
- UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1402)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302610999791
-
-
Attica
-
Athens, Attica, Grèce, 115 27
- Recrutement
- THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1400)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302107700220
-
Athens, Attica, Grèce, 115 22
- Recrutement
- Agios Savvas Regional Cancer Hospital-2nd Medical Oncology Department ( Site 1407)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302106409501
-
Marousi, Attica, Grèce, 151 25
- Recrutement
- Athens Medical Center ( Site 1406)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302107464642
-
Piraeus, Attica, Grèce, 185 37
- Recrutement
- Metaxa Cancer Hospital of Piraeus ( Site 1408)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302132079225
-
-
Thessaly
-
Larissa, Thessaly, Grèce, 411 10
- Recrutement
- University General Hospital of Larissa-Oncology Clinic ( Site 1403)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +302413502124
-
-
-
-
-
Tbilisi, Géorgie, 0112
- Recrutement
- Todua Clinic, LLC ( Site 1204)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995322575757
-
Tbilisi, Géorgie, 0162
- Recrutement
- New Hospitals ( Site 1200)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995 598 988 566
-
Tbilisi, Géorgie, 0177
- Recrutement
- Cancer Research Centre. Mardaleishvili Medical Centre ( Site 1205)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995322430100
-
Tbilisi, Géorgie, 0102
- Recrutement
- American Hospital Network LLC ( Site 1208)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995 571 300 705
-
Tbilisi, Géorgie, 1206
- Complété
- Tbilisi Institute of Medicine ( Site 1206)
-
Tbilisi, Géorgie, 0144
- Complété
- TSMU and Ingorokva High Medical Technology University Clinic LTD ( Site 1201)
-
Tbilisi, Géorgie, 0159
- Recrutement
- "Institute of Clinical Oncology" LTD ( Site 1210)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995599406920
-
-
Adjara
-
Batumi, Adjara, Géorgie, 6000
- Recrutement
- High Technology Hospital Medcenter ( Site 1203)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995596226060
-
Tbilisi, Adjara, Géorgie, 0186
- Recrutement
- Caucasus Medical Centre ( Site 1202)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995 597 550 140
-
-
Imereti
-
Kutaisi, Imereti, Géorgie, 4600
- Recrutement
- JSC "Vian" ( Site 1211)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +995599705858
-
-
-
-
Maharashtra
-
Mumbai, Maharashtra, Inde, 400012
- Recrutement
- Tata Memorial Hospital ( Site 3205)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 02224177000
-
Mumbai, Maharashtra, Inde, 400004
- Actif, ne recrute pas
- Sir H. N. Reliance Foundation Hospital and Research Centre ( Site 3201)
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, Inde, 110076
- Recrutement
- Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3203)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +919426166688
-
New Delhi, National Capital Territory of Delhi, Inde, 110029
- Recrutement
- AIIMS New Delhi Dept of Medicine ( Site 3206)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +91-9650629370
-
-
-
-
-
Padova, Italie, 35131
- Recrutement
- IOV - Istituto Oncologico Veneto IRCCS UOSD - Unità di ricerca clinica ( Site 1603)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390498215649
-
-
Campania
-
Naples, Campania, Italie, 80131
- Recrutement
- Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1607)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390811777029
-
-
Emilia-Romagna
-
Ravenna, Emilia-Romagna, Italie, 48121
- Recrutement
- Ospedale Santa Maria delle Croci ( Site 1606)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390544285247
-
-
Friuli Venezia Giulia
-
Aviano, Friuli Venezia Giulia, Italie, 33081
- Recrutement
- CRO-IRCCS-Clinical Oncology ( Site 1605)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390434309464
-
-
Lazio
-
Rome, Lazio, Italie, 00168
- Recrutement
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1601)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 00390630156318
-
-
Lombardy
-
Milan, Lombardy, Italie, 20133
- Recrutement
- Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1600)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390223903829
-
Milan, Lombardy, Italie, 20141
- Recrutement
- Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1604)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390257489482
-
-
Napoli
-
Naples, Napoli, Italie, 80131
- Recrutement
- A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1602)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0817062652
-
-
Roma
-
Rome, Roma, Italie, 00144
- Recrutement
- Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1609)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +390652662205
-
-
Tuscany
-
Livorno, Tuscany, Italie, 57124
- Recrutement
- Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno-UOC Oncologia Medica Livorno ( Site 1608)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 00390586223416
-
-
-
-
-
Chiba, Japon, 260-8677
- Recrutement
- Chiba University Hospital ( Site 3322)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-43-222-7171
-
Hiroshima, Japon, 730-8518
- Recrutement
- Hiroshima City Hiroshima Citizens Hospital ( Site 3314)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-82-221-2291
-
Kumamoto, Japon, 861-4193
- Recrutement
- Saiseikai Kumamoto Hospital ( Site 3318)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-96-351-8000
-
Niigata, Japon, 951-8520
- Recrutement
- Niigata University Medical & Dental Hospital ( Site 3323)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-25-223-6161
-
Osaka, Japon, 545-8586
- Recrutement
- Osaka Metropolitan University Hospital ( Site 3321)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-6-6645-2121
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japon, 466-8560
- Recrutement
- Nagoya University Hospital ( Site 3309)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-52-741-2111
-
Toyoake, Aichi-ken, Japon, 470-1192
- Recrutement
- Fujita Health University Hospital ( Site 3310)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-562-93-2111
-
-
Chiba
-
Kashiwa, Chiba, Japon, 277-8577
- Recrutement
- National Cancer Center Hospital East ( Site 3303)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-4-7133-1111
-
-
Ehime
-
Matsuyam, Ehime, Japon, 719-0280
- Recrutement
- National Hospital Organization Shikoku Cancer Center ( Site 3315)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-89-999-1111
-
-
Fukuoka
-
Fukuoka, Fukuoka, Japon, 811-1395
- Recrutement
- National Hospital Organization Kyushu Cancer Center ( Site 3316)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-92-541-3231
-
Kurume, Fukuoka, Japon, 830-0011
- Recrutement
- Kurume University Hospital ( Site 3317)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-942-35-3311
-
-
Gunma
-
Ōta, Gunma, Japon, 373-8550
- Recrutement
- Gunma Prefectural Cancer Center ( Site 3302)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-276-38-0771
-
-
Hokkaido
-
Sapporo, Hokkaido, Japon, 060-8543
- Recrutement
- Sapporo Medical University Hospital ( Site 3324)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-11-611-2111
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, Japon, 920-8641
- Recrutement
- Kanazawa University Hospital ( Site 3308)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-76-265-2000
-
-
Kanagawa
-
Kawasaki, Kanagawa, Japon, 216-8511
- Recrutement
- St. Marianna University Hospital ( Site 3320)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-44-977-8111
-
-
Mie-ken
-
Matsusaka, Mie-ken, Japon, 515-8544
- Recrutement
- Saiseikai Matsusaka Municipal Hospital ( Site 3311)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-598-23-1515
-
-
Miyagi
-
Natori-shi, Miyagi, Japon, 981-1293
- Recrutement
- Miyagi Cancer Center ( Site 3301)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-22-384-3151
-
Sendai, Miyagi, Japon, 981-0914
- Recrutement
- Sendai Kousei Hospital ( Site 3300)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-22-222-6181
-
-
Osaka
-
Hirakata, Osaka, Japon, 573-1191
- Recrutement
- Kansai Medical University Hospital ( Site 3312)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-72-804-0101
-
Takatsuki, Osaka, Japon, 569-8686
- Recrutement
- Osaka Medical and Pharmaceutical University Hospital ( Site 3313)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-72-683-1221
-
-
Saitama
-
Kitaadachi-gun, Saitama, Japon, 362-0806
- Recrutement
- Saitama Prefectural Cancer Center ( Site 3304)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-48-722-1111
-
-
Tokyo
-
Bunkyo, Tokyo, Japon, 113-8603
- Recrutement
- Nippon Medical School Hospital ( Site 3306)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-3-3822-2131
-
Shinjuku, Tokyo, Japon, 160-0023
- Recrutement
- Tokyo Medical University Hospital ( Site 3307)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-3-3342-6111
-
Shinjuku, Tokyo, Japon, 162-8655
- Recrutement
- National Center for Global Health and Medicine ( Site 3305)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-3-3202-7181
-
Ōta-ku, Tokyo, Japon, 143-8541
- Recrutement
- Toho University Omori Medical Center ( Site 3319)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +81-3-3762-4151
-
-
-
-
-
Vienna, L'Autriche, 1210
- Recrutement
- Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2400)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0043 1 27700 72212
-
-
Styria
-
Graz, Styria, L'Autriche, 8036
- Recrutement
- Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 2401)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 004331638512183
-
-
-
-
-
México, Mexique, 14080
- Recrutement
- Instituto Nacional de Cancerologia. ( Site 0608)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +525556280400
-
Oaxaca City, Mexique, 68000
- Recrutement
- Oaxaca Site Management Organization S.C. ( Site 0603)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +529515147056
-
-
Mexico City
-
Mexico City, Mexico City, Mexique, 06700
- Recrutement
- Arké SMO S.A. de C.V. ( Site 0602)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 5533345856
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexique, 66460
- Recrutement
- Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +528180883663
-
-
-
-
-
Auckland, Nouvelle-Zélande, 1023
- Recrutement
- Auckland City Hospital ( Site 3400)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +6493074949
-
-
-
-
-
Utrecht, Pays-Bas, 3584 CX
- Recrutement
- Universitair Medisch Centrum Utrecht ( Site 1704)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 00318875555555
-
-
Gelderland
-
Ede, Gelderland, Pays-Bas, 6716 RP
- Recrutement
- Ziekenhuis Gelderse Vallei ( Site 1705)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0318435499
-
Harderwijk, Gelderland, Pays-Bas, 3844 DG
- Recrutement
- Ziekenhuis St. Jansdal-Poli Longziekten ( Site 1701)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0031341463504
-
-
Overijssel
-
Hengelo, Overijssel, Pays-Bas, 7555 DL
- Recrutement
- Ziekenhuisgroep Twente, locatie Almelo ( Site 1706)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +31887087878
-
Zwolle, Overijssel, Pays-Bas, 8025 AB
- Recrutement
- Isala, locatie Zwolle-Poli Longziekten ( Site 1700)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 0031886243254
-
-
-
-
National Capital Region
-
Pasig, National Capital Region, Philippines, 1600
- Recrutement
- The Medical City ( Site 3507)
-
Contact:
- Study Coordinator
- Numéro de téléphone: (02)6356789 loc 5083
-
Quezon City, National Capital Region, Philippines, 1100
- Recrutement
- Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +632 892 46101*1309
-
Quezon City, National Capital Region, Philippines, 1102
- Recrutement
- ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +63287230101
-
Quezon City, National Capital Region, Philippines, 1100
- Actif, ne recrute pas
- Veterans Memorial Medical Center-Section of Oncology ( Site 3505)
-
-
-
-
Lesser Poland Voivodeship
-
Gorlice, Lesser Poland Voivodeship, Pologne, 38-300
- Complété
- Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1801)
-
Krakow, Lesser Poland Voivodeship, Pologne, 30-727
- Complété
- Pratia MCM Krakow ( Site 1808)
-
-
Lublin Voivodeship
-
Lublin, Lublin Voivodeship, Pologne, 20-090
- Recrutement
- Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 1805)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +48 814485180
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Pologne, 02-781
- Recrutement
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1800)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +48225462336
-
-
Podkarpackie Voivodeship
-
Przemyśl, Podkarpackie Voivodeship, Pologne, 37-700
- Recrutement
- Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1804)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +48166775000
-
-
Warmian-Masurian Voivodeship
-
Olsztyn, Warmian-Masurian Voivodeship, Pologne, 10-357
- Recrutement
- Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1809)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +48895322978
-
-
-
-
-
Lima, Pérou, 15036
- Recrutement
- IPOR Instituto Peruano de Oncología & Radioterapia ( Site 4301)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 511 2241598 anex 121
-
-
-
-
-
Brasov, Roumanie, 500052
- Recrutement
- SC ONCO CARD SRL ( Site 1995)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +40268 994
-
Bucharest, Roumanie, 077190
- Recrutement
- SC MNT HEALTHCARE EUROPE SRL ( Site 1991)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +40722927377
-
Cluj-Napoca, Roumanie, 400015
- Recrutement
- Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +40264598362
-
Suceava, Roumanie, 720214
- Recrutement
- Sigmedical Services SRL ( Site 1997)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +4 0330 803 483
-
-
Bucharest
-
Bucharest, Bucharest, Roumanie, 020335
- Recrutement
- Centrul de Diagnostic si Tratament Provita. ( Site 1992)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +4021.9432
-
-
Dolj
-
Craiova, Dolj, Roumanie, 200542
- Recrutement
- Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +40731604432
-
-
Timiș County
-
Timișoara, Timiș County, Roumanie, 300239
- Recrutement
- Cabinet Medical Oncomed ( Site 1998)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +40356460995
-
-
-
-
Buckinghamshire
-
Milton Keynes, Buckinghamshire, Royaume-Uni, MK6 5LD
- Recrutement
- Milton Keynes Hospital ( Site 2304)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 01908 997609
-
-
Devon
-
Exeter, Devon, Royaume-Uni, EX2 5DW
- Recrutement
- Royal Devon & Exeter Hospital-Oncology ( Site 2302)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +44 (0) 1392 402869
-
-
-
-
-
Adana, Turquie (Türkiye), 01140
- Recrutement
- Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2107)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +90 322 456 19 00
-
Ankara, Turquie (Türkiye), 06010
- Recrutement
- SBU GULHANE EGITIM VE ARASTIRMA HASTANESI Onkoloji ( Site 2104)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +905058726378
-
Ankara, Turquie (Türkiye), 06230
- Recrutement
- Hacettepe Universite Hastaneleri-oncology hospital ( Site 2101)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +90 312 305 10 80
-
Ankara, Turquie (Türkiye), 06520
- Recrutement
- Memorial Ankara Hastanesi-Medical Oncology ( Site 2106)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +903122536666
-
Ankara, Turquie (Türkiye), 06800
- Recrutement
- Ankara Bilkent Şehir Hastanesi ( Site 2100)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +903125526000
-
Istanbul, Turquie (Türkiye), 34214
- Recrutement
- Medipol Mega Universite Hastanesi-oncology ( Site 2105)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +902124447044
-
Istanbul, Turquie (Türkiye), 34722
- Recrutement
- TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2103)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +902166065200
-
Sakarya, Turquie (Türkiye), 54290
- Recrutement
- Sakarya Training and Research Hospital ( Site 2109)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +902648884000
-
-
İzmir
-
Balçova, İzmir, Turquie (Türkiye), 35340
- Recrutement
- Dokuz Eylul Universitesi Hastanesi ( Site 2108)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +902323434343
-
Bornova, İzmir, Turquie (Türkiye), 35100
- Recrutement
- Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2102)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +905322202675
-
-
-
-
Cherkasy Oblast
-
Cherkasy, Cherkasy Oblast, Ukraine, 18009
- Complété
- COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 2209)
-
-
Chernivetska Oblast
-
Chernivtsi, Chernivetska Oblast, Ukraine, 58013
- Recrutement
- Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center" ( Site 2210)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380955077568
-
-
Dnipropetrovsk Oblast
-
Kryvyi Rih, Dnipropetrovsk Oblast, Ukraine, 50000
- Recrutement
- Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 2215)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380973567855
-
-
Ivano-Frankivsk Oblast
-
Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine, 76018
- Recrutement
- Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 2202)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380978411455
-
-
Kirovohrad Oblast
-
Kropyvnytskyi, Kirovohrad Oblast, Ukraine, 25011
- Recrutement
- Kirovohrad Regional Oncology Center-Chemotherapy department ( Site 2204)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380508412400
-
-
Kyivska Oblast
-
Kiev, Kyivska Oblast, Ukraine, 03022
- Recrutement
- Medical Center "MedOffice Group" ( Site 2219)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380503858689
-
Kyiv, Kyivska Oblast, Ukraine, 03039
- Recrutement
- LLC Clinic Verum Expert ( Site 2223)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380443835959
-
-
Lviv Oblast
-
Lviv, Lviv Oblast, Ukraine, 79059
- Recrutement
- Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 2217)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380506749772
-
-
Rivne Oblast
-
Rivne, Rivne Oblast, Ukraine, 33007
- Complété
- Rivne Regional Clinical Hospital ( Site 2205)
-
Rivne, Rivne Oblast, Ukraine, 33010
- Recrutement
- ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2920)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380362633075
-
-
Vinnytsia Oblast
-
Vinnytsia, Vinnytsia Oblast, Ukraine, 21029
- Recrutement
- Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 2211)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380953105783
-
-
Volyn Oblast
-
Lutsk, Volyn Oblast, Ukraine, 43018
- Recrutement
- ME Volyn Regional Clinical Hospital of the Volyn Regional Council ( Site 2216)
-
Contact:
- Study Coordinator
- Numéro de téléphone: +380503782998
-
-
-
-
California
-
Bakersfield, California, États-Unis, 93309
- Recrutement
- CBCC Global Research, Inc. ( Site 0123)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 661-322-2206
-
Beverly Hills, California, États-Unis, 90211
- Recrutement
- Beverly Hills Cancer Center ( Site 0116)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 310-432-8955
-
-
Connecticut
-
Stamford, Connecticut, États-Unis, 06902
- Recrutement
- Stamford Hospital ( Site 0136)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 877-233-9355
-
-
Florida
-
Miami Beach, Florida, États-Unis, 33140
- Complété
- Mount Sinai Cancer Center ( Site 0137)
-
-
Illinois
-
Skokie, Illinois, États-Unis, 60077
- Recrutement
- Orchard Healthcare Research Inc. ( Site 0115)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 224-534-7580
-
-
Missouri
-
Kansas City, Missouri, États-Unis, 64108
- Recrutement
- Truman Medical Center ( Site 0126)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 816-404-4093
-
Springfield, Missouri, États-Unis, 65807
- Recrutement
- Cox Medical Center North ( Site 0133)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 417-875-3000
-
-
Montana
-
Billings, Montana, États-Unis, 59102
- Recrutement
- St. Vincent Frontier Cancer Center-Research ( Site 0105)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 402-238-6685
-
-
New Jersey
-
Morristown, New Jersey, États-Unis, 07960
- Complété
- Atlantic Health System Morristown Medical Center ( Site 0121)
-
-
New York
-
Albany, New York, États-Unis, 12206
- Recrutement
- New York Oncology Hematology, P.C. ( Site 0132)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 518-489-3612
-
-
Ohio
-
Cincinnati, Ohio, États-Unis, 45219
- Recrutement
- University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 513-556-6000
-
Kettering, Ohio, États-Unis, 45429
- Complété
- Kettering Health Main Campus-Kettering Health Cancer Center ( Site 0106)
-
-
Pennsylvania
-
Lancaster, Pennsylvania, États-Unis, 17601
- Recrutement
- Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 717-544-9400
-
-
Texas
-
Houston, Texas, États-Unis, 77030
- Recrutement
- Oncology Consultants P.A. ( Site 0113)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 713-600-0900
-
-
Wisconsin
-
Madison, Wisconsin, États-Unis, 53715
- Recrutement
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0129)
-
Contact:
- Study Coordinator
- Numéro de téléphone: 608-410-2767
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
The main inclusion and exclusion criteria include but are not limited to the following:
Inclusion Criteria:
- Has histologically or cytologically confirmed diagnosis of non-small cell lung cancer (NSCLC)
- Has newly diagnosed Stage IIIB/IIIC NSCLC, not eligible for curative resection or curative chemotherapy/radiation as determined by a multidisciplinary tumor board and/or by radiation oncologist, surgeon, and medical oncologist or Stage IV (M1a, M1b, or M1c) by American Joint Committee on Cancer (AJCC) Staging Manual, Version 8
- Provides an archival tumor sample (≤5 years) or newly obtained core, incisional, or excisional biopsy or fine needle aspirate (FNA) of a tumor lesion, not previously irradiated to enable central laboratory testing of kirsten rat sarcoma (KRAS) G12C mutation status, programmed cell death ligand 1 (PD-L1) status, and biomarker research
- If have had adverse events (AEs) due to previous anticancer therapies, must have recovered to < Grade 1 or baseline
- If human immunodeficiency virus (HIV)-infected, must have well controlled HIV on antiretroviral therapy (ART)
- If Hepatitis B surface antigen (HBsAg) positive, have received Hepatitis B Virus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load
- If a participant has a history of Hepatitis C virus (HCV) infection, HCV viral load is undetectable
Exclusion Criteria:
- Has diagnosis of small cell lung cancer. For mixed tumors, if small cell elements are present, the participant is ineligible
- Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease
- Has known history of, or active, neurologic paraneoplastic syndrome
- Has an active infection requiring systemic therapy, with exceptions
- Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
- Has received prior systemic anticancer therapy for their locally advanced or metastatic NSCLC
- Has received radiation therapy to the lung that is >30 Gray within 6 months of start of study intervention
- Has received radiotherapy to non-central nervous system (CNS) disease within 2 weeks of start of study intervention. Participants must have recovered from all radiation-related toxicities, not required corticosteroids, and not have had radiation pneumonitis
- Has known active CNS metastases and/or carcinomatous meningitis
- Known additional malignancy that is progressing or has required active treatment within the past 3 years
- Has active autoimmune disease that has required systemic treatment in the past 2 years
- Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease
- Is HIV-infected and has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease
- Has history of allogenic tissue/solid organ transplant
- Has not fully recovered from any effects of major surgical procedure
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Calderasib with Pembrolizumab
Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and calderasib by oral tablets until discontinuation criterion is met. |
IV infusion
Autres noms:
Oral tablets
Autres noms:
|
|
Comparateur actif: Placebo with Pembrolizumab
Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and placebo by oral tablets once daily until discontinuation criterion is met. |
IV infusion
Autres noms:
Oral tablets |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Progression-Free Survival (PFS)
Délai: Up to approximately 42 months
|
PFS is defined as the time from randomization until either documented disease progression per Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1) or death due to any cause, whichever occurs first. PFS as determined by blinded independent central review (BICR) will be presented. |
Up to approximately 42 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Overall Survival
Délai: Up to approximately 57 months
|
OS is defined as the time from randomization to death due to any cause. |
Up to approximately 57 months
|
|
Objective Response Rate (ORR)
Délai: Up to approximately 42 months
|
ORR is defined as the percentage of participants with Complete Response or Partial Response per RECIST1.1. The percentage of participants who experience CR or PR as assessed by BICR will be presented. |
Up to approximately 42 months
|
|
Duration of Response (DOR)
Délai: Up to approximately 42 months
|
For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first. |
Up to approximately 42 months
|
|
Number of Participants Who Experience One or More Adverse Event (AEs)
Délai: Up to approximately 80 months
|
An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who experience an AE will be presented. |
Up to approximately 80 months
|
|
Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)
Délai: Up to approximately 80 months
|
An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who discontinue study treatment due to an AE will be presented. |
Up to approximately 80 months
|
|
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) Global Health Status (Item 29) and Quality of Life (Item 30) Combined Score
Délai: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. Higher scores indicate a better overall health status. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Physical Functioning (Items 1-5) Score
Délai: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 1-5 will be presented. Higher scores indicate a better level of functioning. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Role Functioning (Items 6-7) Score
Délai: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 6-7 will be presented. Higher scores indicate a better level of functioning. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Dyspnea (Item 8) Score
Délai: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. A higher score indicates a worse level of dyspnea. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module (EORTC QLQ-LC13) Cough (Item 31) Score
Délai: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. A higher score indicates more frequent coughing. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Délai: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 40 will be presented. A higher score indicates a worse level of chest pain. |
Baseline and Up to approximately 24 months
|
|
Time to Deterioration (TTD) in EORTC-QLQ-C30 Global Health Status (Item 29) Quality of Life (Item 30) Combined Score
Délai: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in global health status (GHS) and quality of life (QoL) (EORTC QLQ-C30 Items 29 and 30) score. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in GHS and QoL, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Physical Functioning (Items 1-5) Score
Délai: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in physical functioning (EORTC QLQ-C30 Items 1-5) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in physical functioning score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Role Functioning (Items 6-7) Score
Délai: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in role functioning (EORTC QLQ-C30 Items 6 and 7) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in role functioning score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Dyspnea (Item 8) Score
Délai: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in dyspnea (EORTC QLQ-C30 Item 8) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in dyspnea score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC QLQ-LC13 Cough (Item 31) Score
Délai: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in cough (EORTC QLQ-C13 Item 31) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in cough score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Délai: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in chest pain (EORTC QLQ-C13 Item 40) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline chest pain score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Medical Director, Merck Sharp & Dohme LLC
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Tumeurs par site
- Tumeurs
- Maladies des voies respiratoires
- Maladies pulmonaires
- Tumeurs des voies respiratoires
- Tumeurs thoraciques
- Tumeurs pulmonaires
- Carcinome bronchique
- Tumeurs bronchiques
- Carcinome pulmonaire non à petites cellules
- Maladie de Parkinson 4, corps de Lewy dominant autosomique
- pembrolizumab
Autres numéros d'identification d'étude
- 1084-004
- MK-1084-004 (Autre identifiant: MSD)
- U1111-1296-8093 (Identificateur de registre: UTN)
- jRCT2031240213 (Identificateur de registre: jRCT)
- PHRR241128-007796 (Identificateur de registre: PHRR)
- 2023-507776-42-00 (Identificateur de registre: EU CT)
- KANDLELIT-004 (Autre identifiant: MSD)
- 2023 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .